# A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy

> **NCT06182865** · NA · UNKNOWN · sponsor: **National Atomic Research Institute, Taiwan** · enrollment: 10 (estimated)

## Conditions studied

- Hepatic Carcinoma

## Interventions

- **DRUG:** Ga-68 Dolacga Injection

## Key facts

- **NCT ID:** NCT06182865
- **Lead sponsor:** National Atomic Research Institute, Taiwan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-20
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06182865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06182865, "A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06182865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*